Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V S Mohr

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Endocrinology|April 1, 1985
Iopanoic acid is of minimal benefit in the treatment of severe hyperthyroidism: conclusions from a case studyP S Hamblin, V S Mohr, J R Stockigt, et al.
Clinical Endocrinology|May 1, 1987
Evaluation of T4 and T3 binding kinetics in the thyroxine binding globulin abnormality of Australian aboriginesV S Mohr, J W Barlow, D J Topliss, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1986
Specific methods to identify plasma binding abnormalities in euthyroid hyperthyroxinemiaJ R Stockigt, S A Dyer, V S Mohr, et al.
Clinical Endocrinology|May 1, 1987
Anomalous binding characteristics of human thyroxine binding globulin due to a dilution-dependent separation artefactJ R Stockigt, C F Lim, D J Topliss, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1985
Interaction of furosemide with serum thyroxine-binding sites: in vivo and in vitro studies and comparison with other inhibitorsJ R Stockigt, C F Lim, J W Barlow, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1986
Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illnessP S Hamblin, S A Dyer, V S Mohr, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Endocrinology|April 1, 1985
Iopanoic acid is of minimal benefit in the treatment of severe hyperthyroidism: conclusions from a case studyP S Hamblin, V S Mohr, J R Stockigt, et al.
Clinical Endocrinology|May 1, 1987
Evaluation of T4 and T3 binding kinetics in the thyroxine binding globulin abnormality of Australian aboriginesV S Mohr, J W Barlow, D J Topliss, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1986
Specific methods to identify plasma binding abnormalities in euthyroid hyperthyroxinemiaJ R Stockigt, S A Dyer, V S Mohr, et al.
Clinical Endocrinology|May 1, 1987
Anomalous binding characteristics of human thyroxine binding globulin due to a dilution-dependent separation artefactJ R Stockigt, C F Lim, D J Topliss, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1985
Interaction of furosemide with serum thyroxine-binding sites: in vivo and in vitro studies and comparison with other inhibitorsJ R Stockigt, C F Lim, J W Barlow, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1986
Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illnessP S Hamblin, S A Dyer, V S Mohr, et al.
Pageof 1